113 related articles for article (PubMed ID: 2197640)
1. Mental and behavioural disorders due to psychoactive substance use (section F1): results of the ICD-10 field trial.
Winkler G; Dittmann V; John U; Ladewig D
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():151-4. PubMed ID: 2197640
[TBL] [Abstract][Full Text] [Related]
2. Neurotic, stress-related and somatoform disorders (section F4) and physiological dysfunction associated with mental or behavioural factors (section F5): results of the ICD-10 field trial.
Freyberger HJ; Stieglitz RD; Berner P
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():165-9. PubMed ID: 2197642
[TBL] [Abstract][Full Text] [Related]
3. [Trials with ICD-10: results of a multicenter field study in German speaking countries].
Freyberger HJ; Dittmann V; Stieglitz RD; Dilling H
Nervenarzt; 1990 May; 61(5):271-5. PubMed ID: 2193236
[TBL] [Abstract][Full Text] [Related]
4. ICD-10 field trial in German-speaking countries--summary of the quantitative empirical results.
Freyberger HJ; Albus M; Stieglitz RD
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():192-6. PubMed ID: 2197648
[TBL] [Abstract][Full Text] [Related]
5. Mental and behavioural disorders due to use of psychoactive substances (F1). Results from the ICD-10 field trial of the Diagnostic Criteria for Research in German-speaking countries.
Müssigbrodt H; Dilling H; Dittmann V; Meszaros K
Psychopathology; 1996; 29(5):274-9. PubMed ID: 8936605
[TBL] [Abstract][Full Text] [Related]
6. Organic, including symptomatic, mental disorders (section F0)--results of the ICD-10 field trial.
Gutzmann H; Krüger H; Neumann EM
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():146-50. PubMed ID: 2197639
[TBL] [Abstract][Full Text] [Related]
7. Feasibility, suitability, and interrater reliability of ICD-10 during different stages of the ICD-10 field trial.
Stieglitz RD; Zaudig M; Freyberger HJ; Dittmann V
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():188-91. PubMed ID: 2197647
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of adult personality and behaviour (section F 6)--results of the ICD-10 field trial.
Dittmann V; von Cranach M; Eckermann G
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():170-2. PubMed ID: 2197643
[TBL] [Abstract][Full Text] [Related]
9. ICD-10 field trial in German-speaking countries--summary, judgement and perspectives.
Dittmann V; Freyberger HJ; Albus M; Blanz B; von Cranach M; Gastpar M; Gutzmann H; Maier W; Mombour W; Stieglitz RD
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():202-4. PubMed ID: 2197650
[TBL] [Abstract][Full Text] [Related]
10. Design of the ICD-10 field trial in German-speaking countries.
Dilling H; Freyberger HJ; Malchow CP
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():142-5. PubMed ID: 2197638
[TBL] [Abstract][Full Text] [Related]
11. Schizophrenia, schizotypal and delusional disorders (section F2): results of the ICD-10 field trial.
Albus M; Strauss A; Stieglitz RD
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():155-9. PubMed ID: 2197641
[TBL] [Abstract][Full Text] [Related]
12. Chapter V (F) of ICD-10: mental, behavioural and developmental disorders--introduction and overview.
Dittmann V; Dilling H
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():137-41. PubMed ID: 2197637
[TBL] [Abstract][Full Text] [Related]
13. [Hallucinogen induced psychic disorders. Subjective experiences, psychopathology and differential diagnosis].
Hermle L; Gouzoulis-Mayfrank E; Spitzer M
Fortschr Neurol Psychiatr; 1996 Dec; 64(12):482-91. PubMed ID: 9053389
[TBL] [Abstract][Full Text] [Related]
14. Summary of the qualitative criticisms made during the ICD-10 field trial and remarks on the German translation of ICD-10.
Mombour W; Spitzner S; Reger KH; von Cranach M; Dilling H; Helmchen H
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():197-201. PubMed ID: 2197649
[TBL] [Abstract][Full Text] [Related]
15. [Substance-induced disorders: moving towards DSM-V and ICD-11].
Schmidt LG
Fortschr Neurol Psychiatr; 2006 Nov; 74(11):634-42. PubMed ID: 16586255
[TBL] [Abstract][Full Text] [Related]
16. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
[TBL] [Abstract][Full Text] [Related]
17. [Operationalized Psychodynamic Diagnosis in a trial--results of multicenter acceptability and practicability study].
Freyberger HJ; Dierse B; Schneider W; Strauss B; Heuft G; Schauenburg H; Pouget-Schors D; Seidler GH; Küchenhoff J; Janssen PL; Hoffmann SO
Psychother Psychosom Med Psychol; 1996; 46(9-10):356-66. PubMed ID: 8975271
[TBL] [Abstract][Full Text] [Related]
18. A review of comorbidity: major mental illness and problematic substance use.
Cohen SI
Aust N Z J Psychiatry; 1999 Aug; 33(4):601. PubMed ID: 10483859
[No Abstract] [Full Text] [Related]
19. Comparison of the ICD-10-classification with the ICD-9- and the DSM-III-classification of mental disorders.
Maier W; Philipp M; Zaudig M
Pharmacopsychiatry; 1990 Jun; 23 Suppl 4():183-7. PubMed ID: 2197646
[TBL] [Abstract][Full Text] [Related]
20. [Reference tables of WHO Chapter V (F) of the 10th revision of the International Classification of Diseases (ICD-10): ICD-9 vs. ICD-10].
Freyberger HJ; Schulte-Markwort E; Dilling H
Fortschr Neurol Psychiatr; 1993 Apr; 61(4):109-27. PubMed ID: 8509009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
